ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Tobacco Company Liggett Gave $3.6 Million To Henschke For CT Screening Research.

March 28, 2008

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

GM Cancer Research Foundation Awards $750,000 To Five Scientists For Their Work

June 8, 2001

ASCO Weighs In On Tobacco Debate

September 19, 1997

GM Sends STAR Information To Its Female Employees.

February 23, 2001

Conte To Introduce Bill To Stem Loss Of NIH “Superstars”

March 31, 1989